| 1. Executive Summary |
| 2. Global Next Generation Biomanufacturing Market Introduction |
| 2.1. Global Next Generation Biomanufacturing Market – Taxonomy |
| 2.2. Global Next Generation Biomanufacturing Market –Definitions |
| 2.2.1. By Type |
| 2.2.2. By Application |
| 2.2.3. By End-Use |
| 3. Global Next Generation Biomanufacturing Market Dynamics |
| 3.1. Drivers |
| 3.2. Restraints |
| 3.3. Opportunities/Unmet Needs of the Market |
| 3.4. Trends |
| 3.5. Global Next Generation Biomanufacturing Market Dynamic Factors - Impact Analysis |
| 3.6. Global Next Generation Biomanufacturing Market – Competition Landscape |
| 3.7. Epidemiology |
| 4. Global Next Generation Biomanufacturing Market Analysis,2017-2021 and Forecast, 2022-2028 |
| 4.1. Market Analysis,2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
| 4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) |
| 4.3. Market Opportunity Analysis |
| 5. Global Next Generation Biomanufacturing Market, By Type, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
| 5.1. Continuous Upstream Biomanufacturing |
| 5.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
| 5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.1.3. Market Opportunity Analysis |
| 5.2. Single-Use Upstream Biomanufacturing |
| 5.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
| 5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.2.3. Market Opportunity Analysis |
| 5.3. Downstream Biomanufacturing |
| 5.3.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
| 5.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.3.3. Market Opportunity Analysis |
| 6. Global Next Generation Biomanufacturing Market Forecast, Application, 2017-2021 and Forecast, 2021 – 2027 (Revenue, USD Mn) |
| 6.1. Monoclonal Antibodies |
| 6.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
| 6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.1.3. Market Opportunity Analysis |
| 6.2. Hormones |
| 6.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
| 6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.2.3. Market Opportunity Analysis |
| 6.3. Vaccines |
| 6.3.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
| 6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.3.3. Market Opportunity Analysis |
| 6.4. Recombinant Proteins |
| 6.4.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
| 6.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.4.3. Market Opportunity Analysis |
| 6.5. Others |
| 6.5.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
| 6.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.5.3. Market Opportunity Analysis |
| 7. Global Next Generation Biomanufacturing Market, By End User, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
| 7.1. Biopharmaceutical Companies |
| 7.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
| 7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.1.3. Market Opportunity Analysis |
| 7.2. Research Institutions |
| 7.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
| 7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.2.3. Market Opportunity Analysis |
| 7.3. CMOs/CDMOs |
| 7.3.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
| 7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.3.3. Market Opportunity Analysis |
| 8. Global Next Generation Biomanufacturing Market Forecast, By Region, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
| 8.1. North America |
| 8.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
| 8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.1.3. Market Opportunity Analysis |
| 8.2. Europe |
| 8.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
| 8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.2.3. Market Opportunity Analysis |
| 8.3. Asia-Pacific |
| 8.3.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
| 8.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.3.3. Market Opportunity Analysis |
| 8.4. Latin America |
| 8.4.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
| 8.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.4.3. Market Opportunity Analysis |
| 8.5. Middle East and Africa |
| 8.5.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
| 8.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.5.3. Market Opportunity Analysis |
| 8.6. Global Next Generation Biomanufacturing Market - Opportunity Analysis Index, By Type, Application, End User, and Region, 2022-2028 |
| 9. North America Next Generation Biomanufacturing MarketAnalysis,2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
| 9.1. By Type Analysis 2017-2021 and Forecast 2022-2028by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 9.1.1. Continuous Upstream Biomanufacturing |
| 9.1.2. Single-Use Upstream Biomanufacturing |
| 9.1.3. Downstream Biomanufacturing |
| 9.2. Application Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 9.2.1. Monoclonal Antibodies |
| 9.2.2. Hormones |
| 9.2.3. Vaccines |
| 9.2.4. Recombinant Proteins |
| 9.2.5. Others |
| 9.3. End User Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 9.3.1. Biopharmaceutical Companies |
| 9.3.2. Research Institutions |
| 9.3.3. CMOs/CDMOs |
| 9.4. Country Analysis 2017-2021 and Forecast 2022-2028by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
| 9.4.1. USA |
| 9.4.2. Canada |
| 9.5. North America Next Generation Biomanufacturing Market - Opportunity Analysis Index, By Type, Application, End User, and Country, 2022-2028 |
| 9.6. North America Next Generation Biomanufacturing Market Dynamics – Trends |
| 10. Europe Next Generation Biomanufacturing Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
| 10.1. By Type Analysis 2017-2021 and Forecast 2022-2028by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 10.1.1. Continuous Upstream Biomanufacturing |
| 10.1.2. Single-Use Upstream Biomanufacturing |
| 10.1.3. Downstream Biomanufacturing |
| 10.2. Application Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 10.2.1. Monoclonal Antibodies |
| 10.2.2. Hormones |
| 10.2.3. Vaccines |
| 10.2.4. Recombinant Proteins |
| 10.2.5. Others |
| 10.3. End User Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 10.3.1. Biopharmaceutical Companies |
| 10.3.2. Research Institutions |
| 10.3.3. CMOs/CDMOs |
| 10.4. Country Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
| 10.4.1. Germany |
| 10.4.2. UK |
| 10.4.3. France |
| 10.4.4. Spain |
| 10.4.5. Italy |
| 10.4.6. Russia |
| 10.4.7. Poland |
| 10.4.8. Rest of Europe |
| 10.5. Europe Next Generation Biomanufacturing Market - Opportunity Analysis Index, By Type, Application, End User, and Country, 2022-2028 |
| 10.6. Europe Next Generation Biomanufacturing Market Dynamics – Trends |
| 11. Asia-Pacific Next Generation Biomanufacturing Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
| 11.1. By Type Analysis 2017-2021 and Forecast 2022-2028by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 11.1.1. Continuous Upstream Biomanufacturing |
| 11.1.2. Single-Use Upstream Biomanufacturing |
| 11.1.3. Downstream Biomanufacturing |
| 11.2. Application Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 11.2.1. Monoclonal Antibodies |
| 11.2.2. Hormones |
| 11.2.3. Vaccines |
| 11.2.4. Recombinant Proteins |
| 11.2.5. Others |
| 11.3. End User Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 11.3.1. Biopharmaceutical Companies |
| 11.3.2. Research Institutions |
| 11.3.3. CMOs/CDMOs |
| 11.4. Country Analysis2017-2021 and Forecast 2022-2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
| 11.4.1. Japan |
| 11.4.2. China |
| 11.4.3. India |
| 11.4.4. ASEAN |
| 11.4.5. Australia & New Zealand |
| 11.4.6. Rest of Asia-Pacific |
| 11.5. Asia-Pacific Next Generation Biomanufacturing Market - Opportunity Analysis Index, By Type, Application, End User, and Country, 2022-2028 |
| 11.6. Asia-Pacific Next Generation Biomanufacturing Market Dynamics – Trends |
| 12. Latin America Next Generation Biomanufacturing Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
| 12.1. By Type Analysis 2017-2021 and Forecast 2022-2028by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 12.1.1. Continuous Upstream Biomanufacturing |
| 12.1.2. Single-Use Upstream Biomanufacturing |
| 12.1.3. Downstream Biomanufacturing |
| 12.2. Application Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 12.2.1. Monoclonal Antibodies |
| 12.2.2. Hormones |
| 12.2.3. Vaccines |
| 12.2.4. Recombinant Proteins |
| 12.2.5. Others |
| 12.3. End User Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 12.3.1. Biopharmaceutical Companies |
| 12.3.2. Research Institutions |
| 12.3.3. CMOs/CDMOs |
| 12.4. Country Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
| 12.4.1. Brazil |
| 12.4.2. Mexico |
| 12.4.3. Argentina |
| 12.4.4. Rest of Latin America |
| 12.5. Latin America Next Generation Biomanufacturing Market - Opportunity Analysis Index, By Type, Application, End User, and Country, 2022-2028 |
| 12.6. Latin America Next Generation Biomanufacturing Market Dynamics – Trends |
| 13. Middle East and Africa Next Generation Biomanufacturing Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
| 13.1. By Type Analysis 2017-2021 and Forecast 2022-2028by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 13.1.1. Continuous Upstream Biomanufacturing |
| 13.1.2. Single-Use Upstream Biomanufacturing |
| 13.1.3. Downstream Biomanufacturing |
| 13.2. Application Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 13.2.1. Monoclonal Antibodies |
| 13.2.2. Hormones |
| 13.2.3. Vaccines |
| 13.2.4. Recombinant Proteins |
| 13.2.5. Others |
| 13.3. End User Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 13.3.1. Biopharmaceutical Companies |
| 13.3.2. Research Institutions |
| 13.3.3. CMOs/CDMOs |
| 13.4. Country Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
| 13.4.1. Gulf Cooperation Council (GCC) Countries |
| 13.4.2. Israel |
| 13.4.3. South Africa |
| 13.4.4. Rest of MEA |
| 13.5. MEA Next Generation Biomanufacturing Market - Opportunity Analysis Index, By Type, Application, End User, and Country, 2022-2028 |
| 13.6. MEA Next Generation Biomanufacturing Market Dynamics – Trends |
| 14. Competition Landscape |
| 14.1. Strategic Dashboard of Top Market Players |
| 14.2. Company Profiles (Introduction, Financial Analysis, Application& Service Offerings, Key Developments, Strategies, and SWOT Analysis) |
| 14.2.1. Merck KGaA |
| 14.2.2. Thermo Fisher Scientific Inc., |
| 14.2.3. Eppendorf AG |
| 14.2.4. Danaher Corporation |
| 14.2.5. GEA Group Aktiengesellschaft |
| 14.2.6. Sartorius AG |
| 14.2.7. bbi-biotech GmbH |
| 14.2.8. Solaris Biotechnology Srl |
| 14.2.9. Esco Group of Companies |
| 14.2.10. Modern Meadow |
| 15. Research Methodology |
| 16. Key Assumptions and Acronyms |
hghLatin America Got Significant Share
Next Generation Biomanufacturing Market
Latin America
Europe
Asia Pacific
Middle East
North America
Key Features of the Reports
- The report provides granular level information about the market size, regional market share, historic market (2019-2023), and forecast (2024-2030)
- The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
- The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
- The report tracks recent innovations, key developments, and start-up details that are actively working in the market
- The report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenario
Frequently Asked Questions
2021 is the base year and 2028 is the forecast year.
In our report, we provide 12-15 market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.
- Merck KGaA
- Thermo Fisher Scientific Inc.,
- Eppendorf AG
- Danaher Corporation
- GEA Group Aktiengesellschaft
- Sartorius AG
- bbi-biotech GmbH
- Solaris Biotechnology Srl
- Esco Group of Companies
- Modern Meadow